Accendra Health Inc (ACH) revenue and earnings history
Accendra Health Inc reported revenue of $2.76B for fiscal 2025 (year ended Dec 31, 2025), +3.1% on the year before, and net income of −$1.1B.
Over 17 years, from fiscal 2008 to fiscal 2025, revenue grew at a compound rate of −5.5% a year.
Revenue and net income, 18 fiscal years
Annual figures, newest first
| Fiscal year | Revenue | Operating income | Net income | Operating cash flow | Capital expenditure | Free cash flow | Stock-based pay | Share buybacks | Dividends paid | Cash at year end | Total debt at year end | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025ended Dec 31, 2025 | $2.76B+3.1% | $27.5M | −$1.1B | −$102M | $191M | −$293M | $12.9M | $10.2M | — | $282M | $2.05B | 10-K |
| 2024ended Dec 31, 2024 |
The latest quarter, insider trades and fund moves: Accendra Health Inc (ACH) on OQRO.
Common questions
What was Accendra Health Inc's revenue in fiscal 2025?
$2.76B for the year ended Dec 31, 2025, as reported in its 10-K filed Feb 20, 2026. That is +3.1% on fiscal 2024 ($2.68B).
How fast has Accendra Health Inc's revenue grown?
From $7.24B in fiscal 2008 to $2.76B in fiscal 2025: a compound annual growth rate of −5.5% over 17 years. This is arithmetic on the filed figures and says nothing about the years ahead.
Where these figures come from
The SEC’s companyfacts data: every figure Accendra Health Inc tagged in XBRL in its annual and quarterly reports since 2009 (some reports carry a few earlier years as comparatives). For each fiscal year OQRO keeps the twelve-month totals from the annual report and the cash and debt at year end, and when a later report restates a year, the later figure. Read again whenever the company files.
Figures are as reported, in US dollars, with no adjustment for acquisitions, disposals or one-off items. Earnings per share are left out because a stock split changes them between reports. This page describes the past and is not investment advice. No language model wrote it.